Compare FND & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FND | TFX |
|---|---|---|
| Founded | 2000 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.3B |
| IPO Year | 2014 | 1994 |
| Metric | FND | TFX |
|---|---|---|
| Price | $47.73 | $129.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $73.44 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 2.9M | 939.4K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 1.05 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $4,684,088,000.00 | $1,992,713,000.00 |
| Revenue This Year | $7.53 | $15.97 |
| Revenue Next Year | $7.68 | $5.15 |
| P/E Ratio | $131.76 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $46.47 | $100.18 |
| 52 Week High | $92.41 | $139.67 |
| Indicator | FND | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 54.51 |
| Support Level | $46.50 | $117.57 |
| Resistance Level | $55.38 | $134.47 |
| Average True Range (ATR) | 2.46 | 4.46 |
| MACD | 0.11 | -0.51 |
| Stochastic Oscillator | 18.02 | 54.92 |
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.